Small extracellular vesicles (sEVs) are known to be secreted by a vast majority of cells.
These sEVs, specifically exosomes, induce specific cell-to-cell interactions and can activate …

Extracellular vesicles (EVs) secreted by all cell types are involved in the cell-to-cell transfer
of regulatory factors that influence cell and tissue phenotypes in normal and diseased …

Exosomes and extracellular vesicles (EV) are increasingly being explored as circulating
biomarkers, but their heterogenous composition will likely mandate the development of …

Extracellular vesicles (EVs) and their cargo constitute novel biomarkers. EV subpopulations
have been defined not only by abundant tetraspanins (eg, CD9, CD63 and CD81) but also …

Extracellular vesicles (EVs) are complex lipid membrane vehicles with variable expressions
of molecular cargo, composed of diverse subpopulations that participate in the intercellular …

Triple-negative breast cancer (TNBC) is a highly metastatic and heterogeneous type of
breast cancer with poor outcomes. Precise, non-invasive methods for diagnosis, monitoring …

Neuron-derived extracellular vesicles (NDEVs) are potential biomarkers of neurological
diseases although their reliable molecular target is not well established. Here, we …

Extracellular vesicles (EVs) are continually released from cancer cells into biofluids, carrying
actionable molecular fingerprints of the underlying disease with considerable diagnostic and …

MicroRNAs (miRNAs) in extracellular vesicles (EVs) play essential roles in cancer initiation
and progression. Quantitative measurements of EV miRNAs are critical for cancer diagnosis …

Specific detection of tumor-derived EVs (tEVs) in plasma is complicated by nontumor EVs
and non-EV particles. To accurately identify tEVs and profile their surface protein expression …